Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
302.00    0.50 (0.17%)
Bid:
302.00
Ask:
302.50
Spread: 0.50 (0.166%)
Market Cap: £178.29m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Disposal

8 May 2018 07:15

RNS Number : 3070N
Treatt PLC
08 May 2018
 

 

 

8 May 2018

 

TREATT PLC

("Treatt" or "the Group")

 

Sale of Earthoil Plantations Limited ("Earthoil Plantations")

 

Treatt, the manufacturer and supplier of innovative ingredient solutions for the flavour, fragrance, beverage and consumer product industries, is pleased to announce the conditional sale of Earthoil Plantations, a wholly owned subsidiary of Treatt, which specialises in the supply of pure, organic, fair trade essential and cold pressed vegetable seed oils for the personal care and cosmetic industries, to Univar Limited (the "Buyer") (the "Sale"). Subject to the satisfaction of certain conditions, the Sale is expected to complete on 31 May 2018 ("Completion").

 

The consideration of £11m (subject to an adjustment based on Earthoil Plantations' actual trading performance in April and May 2018), is receivable in cash in two stages; 90% on Completion and a deferred payment of 10% twelve months after Completion.

 

The Group launched its updated five-year strategic plan in 2017. The new strategic plan, to drive the business through to 2022, is clearly focused on the Group's key product categories of citrus, sugar reduction and tea. Given that strategy, the Board considered personal care ingredients as non-core and this sale is the result of a process undertaken to realise value for the Group.

 

The Sale does not include the Kenyan subsidiaries which will continue to supply Earthoil Plantations under a three-year supply agreement. Transitional services arrangements with Earthoil Plantations have also been agreed for an initial limited period of up to six months from completion.

 

The Group intends to use the proceeds from the Sale to strengthen its balance sheet, and thereby increasing debt capacity for future growth and investment in the Group's key product categories. The Sale is expected to be slightly earnings dilutive for the current financial year ending 30 September 2018.

 

The audited financial results of Earthoil Plantations for the year ended 30 September 2017 showed revenues of £7.7m (2016: £7.9m) and pre-tax profit of £1.18m (2016: £1.05m). The gross assets of Earthoil Plantations were £7.0m as at 31 March 2018.

 

Commenting on the Sale, Group CEO, Daemmon Reeve, said:

 

"As Treatt continues to grow and we embark on our revised 2022 strategy, Earthoil Plantations has become non-core to the Group. This sale will allow us to focus our efforts and resources on developing our business in the global supply of innovative ingredient solutions to the flavour, fragrance, beverage and consumer product industries.

 

May I take this opportunity to thank everyone at Earthoil Plantations for the contribution they have made to Treatt over the past ten years. I am proud to have seen the business develop under Treatt's ownership and wish the company and its employees a bright future under new ownership."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

Enquiries:

 

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Broker

Investec Investment Banking

Patrick Robb +44 (0)20 7597 5970

David Anderson

Alex Wright

 

Public relations

DRD Partnership

Lawrence Dore +44 (0)20 3865 5971

 

About the Group

Treatt is a global, independent supplier of innovative ingredient solutions for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America, Africa and Asia and has manufacturing facilities in the UK, USA and Kenya. Its international foot print enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISUGUUGAUPRUQR
Date   Source Headline
4th Oct 202110:30 amRNSDirector/PDMR Shareholding
21st Sep 20212:25 pmRNSChange of Registered Office
21st Sep 202111:50 amRNSDirector/PDMR Shareholding
21st Sep 20219:50 amRNSHolding(s) in Company
15th Sep 20213:02 pmRNSHolding(s) in Company
9th Sep 20219:59 amRNSStandard form for notification of major holdings
8th Sep 20215:24 pmRNSNotification of Transactions of Directors and PCA
3rd Sep 20215:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20215:38 pmRNSNotification of Transaction of Director & PCA
25th Aug 20211:20 pmRNSHolding(s) in Company
23rd Aug 20215:05 pmRNSHolding(s) in Company
18th Aug 202112:30 pmRNSDirector/PDMR Shareholding
17th Aug 20217:00 amRNSBoard Change
13th Aug 20216:25 pmRNSDirector/PDMR Shareholding
9th Aug 20211:50 pmRNSNotification of Transactions of Director
20th Jul 20215:50 pmRNSHolding(s) in Company
14th Jul 20214:17 pmRNSNotification of Transactions of a PCA
14th Jul 20214:15 pmRNSDirector/PDMR Shareholding
30th Jun 20217:00 amRNSBoard Update
24th Jun 20215:16 pmRNSHolding(s) in Company
10th Jun 202111:25 amRNSHolding(s) in Company
10th Jun 202110:00 amRNSBoard Change
1st Jun 20215:14 pmRNSBlock Listing Six Monthly Return
1st Jun 20215:13 pmRNSBlock Listing Six Monthly Return
26th May 202111:57 amRNSDirector Declaration
20th May 20213:57 pmRNSDirector Declaration
19th May 20217:00 amEQSTreatt (TET): Sweet upgrades
12th May 20214:35 pmRNSHolding(s) in Company
11th May 20216:02 pmRNSHalf Year Results – Replacement
11th May 20217:00 amRNSHalf Year Results
21st Apr 20213:46 pmRNSHolding(s) in Company
12th Apr 20217:00 amRNSTrading Update
9th Apr 20214:32 pmRNSHolding(s) in Company
1st Apr 20214:18 pmRNSTotal Voting Rights
22nd Mar 20215:35 pmRNSDirector/PDMR Shareholding
26th Feb 20217:00 amRNSAppointment of Joint Broker
23rd Feb 20213:33 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSHolding(s) in Company
29th Jan 20211:59 pmRNSResult of AGM
22nd Jan 20217:00 amRNSTrading Update
13th Jan 20214:40 pmRNSDirector/PDMR Shareholding
12th Jan 20213:20 pmRNSDirector/PDMR Shareholding
11th Jan 20219:27 amRNSDirector Declaration
21st Dec 20203:23 pmRNSTotal Voting Rights
21st Dec 202010:28 amRNSChanges to 2021 AGM Arrangements
16th Dec 20205:16 pmRNSDirector/PDMR Shareholding
11th Dec 20201:30 pmRNSBlock Listing Return
10th Dec 20205:21 pmRNSBlock Listing Return
8th Dec 202011:04 amRNSAnnual Financial Report
24th Nov 20207:00 amRNSFull Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.